180 related articles for article (PubMed ID: 27994392)
1. Bottle Characteristics of Topical International Glaucoma Medications versus Local Brands in Saudi Arabia.
Al-Jumaian N; Malik R; Khandekar R; Al-Humaidan A; Al-Madany R; Al-Qahtani R; Altowairqi A; Al-Theeb A; Zaman B; Al-Djasim L; Craven ER; Edward DP
Middle East Afr J Ophthalmol; 2016; 23(4):296-301. PubMed ID: 27994392
[TBL] [Abstract][Full Text] [Related]
2. Generic versus brand-name North American topical glaucoma drops.
Mammo ZN; Flanagan JG; James DF; Trope GE
Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
[TBL] [Abstract][Full Text] [Related]
3. Ability of Bottle Cap Color to Facilitate Accurate Patient-Physician Communication Regarding Medication Identity in Patients with Glaucoma.
Dave P; Villarreal G; Friedman DS; Kahook MY; Ramulu PY
Ophthalmology; 2015 Dec; 122(12):2373-9. PubMed ID: 26260280
[TBL] [Abstract][Full Text] [Related]
4. The Utility of Cap Color and Bottle Characteristics for Topical Glaucoma Therapy.
Marando CM; Seibold LK; SooHoo JR; Pantcheva MB; Ramulu PY; Kahook MY
Ophthalmology; 2015 Dec; 122(12):2577-8. PubMed ID: 26077575
[No Abstract] [Full Text] [Related]
5. Generic glaucoma drop bottle cap colours.
Hallaji NAE; Trope GE
Can J Ophthalmol; 2016 Oct; 51(5):392-393. PubMed ID: 27769334
[No Abstract] [Full Text] [Related]
6. Squeeze Me if You Can: Variability in Force Requirements to Extract a Drop From Common Glaucoma Bottles.
Moore DB; Hammer JD; Akhtari R; Beck J; Sanders S; Kryscio RJ
J Glaucoma; 2016 Sep; 25(9):780-4. PubMed ID: 27552516
[TBL] [Abstract][Full Text] [Related]
7. Evaluating eye drop instillation technique in glaucoma patients.
Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
Salyani A; Birt C
Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
[TBL] [Abstract][Full Text] [Related]
9. The physical properties of generic latanoprost ophthalmic solutions are not identical.
Kolko M; Koch Jensen P
Acta Ophthalmol; 2017 Jun; 95(4):370-373. PubMed ID: 28229536
[TBL] [Abstract][Full Text] [Related]
10. An objective evaluation of eyedrop instillation in patients with glaucoma.
Stone JL; Robin AL; Novack GD; Covert DW; Cagle GD
Arch Ophthalmol; 2009 Jun; 127(6):732-6. PubMed ID: 19506189
[TBL] [Abstract][Full Text] [Related]
11. Dosage variability of topical ocular hypotensive products: a densitometric assessment.
Gaynes BI; Singa RM; Cao Y
J Glaucoma; 2009 Feb; 18(2):149-52. PubMed ID: 19225353
[TBL] [Abstract][Full Text] [Related]
12. An objective assessment of the variability in number of drops per bottle of glaucoma medication.
Moore DB; Beck J; Kryscio RJ
BMC Ophthalmol; 2017 May; 17(1):78. PubMed ID: 28532424
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations.
Angmo D; Wadhwani M; Velpandian T; Kotnal A; Sihota R; Dada T
Int Ophthalmol; 2017 Apr; 37(2):423-428. PubMed ID: 27334605
[TBL] [Abstract][Full Text] [Related]
14. Preservative content in generic and brand name glaucoma eye drops.
Hallaji NA; Rao PP; Trope GE
Can J Ophthalmol; 2016 Dec; 51(6):492. PubMed ID: 27938964
[No Abstract] [Full Text] [Related]
15. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
Queen JH; Feldman RM; Lee DA
Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
[TBL] [Abstract][Full Text] [Related]
16. A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry.
Kahook MY; Fechtner RD; Katz LJ; Noecker RJ; Ammar DA
Curr Eye Res; 2012 Feb; 37(2):101-8. PubMed ID: 22040280
[TBL] [Abstract][Full Text] [Related]
17. Force requirements in topical medicine use--the squeezability factor.
Connor AJ; Severn PS
Eye (Lond); 2011 Apr; 25(4):466-9. PubMed ID: 21293499
[TBL] [Abstract][Full Text] [Related]
18. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
[TBL] [Abstract][Full Text] [Related]
19. Mirror-hat device as a drop delivery aid: a pilot study.
Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
Can J Ophthalmol; 2014 Aug; 49(4):333-8. PubMed ID: 25103649
[TBL] [Abstract][Full Text] [Related]
20. Black eye drop bottle tips improve compliance.
Stack RR; McKellar MJ
Clin Exp Ophthalmol; 2004 Feb; 32(1):39-41. PubMed ID: 14746589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
